期刊文献+

RNA干扰bcl-2基因的筛选及对肝星状细胞生物活性的影响 被引量:2

Screening of RNA interference to bcl-2 gene and the effect on biological behaviors of hepatic stellate cells
下载PDF
导出
摘要 目的研究小干扰RNA(shRNA)重组载体介导抑制大鼠肝星状细胞(hepaticstellatecell,HSC)bcl-2基因的表达,初步观察其对HSC生物活性的影响。方法设计有小发夹结构的3条DNA序列构建重组质粒载体pGPU6-GFP,脂质体转染HSC—T6细胞株以荧光定量PCR和Westernblot筛选鉴定,通过CCK-8法及AnnexinV/PI双标记流式细胞术检测、观察其对HSC生长的影响。结果pGPU6-GFP—shRNA1、shRNA2均能抑制bcl-2mRNA和蛋白表达(P〈0.05),pGPU6-GFP—shRNAl转染HSC.T6株72h后对bcl-2基因抑制达80%,且HSC—T6体外生长明碌受到抑制,早期凋亡率为33.34%~44.12%。结论bel-2小发夹RNA重组载体shRNA1能最有效抑制HSC—T6中bcl-2的表达与细胞生长,促进凋亡,为下一步探索肝纤维化基因治疗提供实验依据。 Objective To investigate the effect of small hairpin RNA (shRNA) targeting bcl-2 gene on the bcl-2 expression and the biological behaviors of hepatic stellate cells (HSCs). Methods Three designed DNA sequences with small hairpin structure were cloned into the transeripted carrier pGPU6-GFP which was transfected into HSC-T6 by lipofectamine. The expression of bcl-2 was screened by real-time PCR and Western blot. The cell proliferation was assayed by CCK-8 method and the cell apoptosis by flow cytometry. Results pGPU6-GFP-shRNA1 , shRNA2 could inhibit the expression bcl-2 mRNA and protein (P 〈 0.05) , pGPU6-GFP-shRNA1 of which was the most effective one with 80% inhibition rate, significantly decreasing the proliferating activity of HSC ( P 〈 0.05 ) , but increasing the apoptosis rate 33.34% -44.12%. Conclusion The constructed bcl-2 shRNA expressing plasmid of pGPU6-GFP-shRNA1 an reduce the expression of bcl-2 at maximum, inhibit the proliferation of HSC and induce apoptosis. Experimental basis is provided for gene therapy of liver fibrosis.
出处 《胃肠病学和肝病学杂志》 CAS 2008年第9期758-761,共4页 Chinese Journal of Gastroenterology and Hepatology
关键词 小干扰RNA 肝星状细胞 肝纤维化 Small hairpin RNA Hepatic stellate cell Liver cirrhosis
  • 相关文献

参考文献7

  • 1Novo E, Marra F, Zamara E, et al. Overexpression of Bcl-2 by activated human hepatic stellate cells : resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans[ J ]. Gut, 2006, 55 (8) : 1174-1182.
  • 2Mutluay R, Ozenirler S, Poyraz A. The expression of bcl-2 in chronic liver diseases[J]. Saudi Med J, 2005, 26(8) :1245-1249.
  • 3Arocho A, Chen B, Ladanyi M, et al. Validation of the 2-DeltaDehaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts[J].Diagn Mol Pathol, 2006, 15 ( 1 ) : 56-61.
  • 4Oancea M, Mazumder S, Crosby ME, et al. Apoptosis assays [ J]. Methods Mol Med, 2006, 129:279-290.
  • 5Kawada N. Human hepatic stellate cells are resistant to apoptosis: implications for human fibrogenie liver disease[J]. Gut, 2006, 55(8) : 1073-1074.
  • 6Fu GF, Lin XH, Han QW, et al. RNA interference remarkably suppresses bcl-2 gene expression in cancer cells in vitro and in vivo[ J]. Cancer Biol Ther, 2005, 4 (8) :822-829.
  • 7Nicholson DW. From bench to climic with apoptosis-based therapeutic agents[J]. Nature, 2000, 407(6805) :810-816.

同被引文献18

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部